secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZyVersa Therapeutics, Inc. (ZVSA)
CIK:        0001859007
Form:       8-K
Filed at:   2023-06-12T23:59:59+00:00
Accession:  0001493152-23-020803
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

ZyVersa receives Nasdaq delisting notice for $1.00 bid price non-compliance
---------------------------------------------------------------------------

- Received Nasdaq notice on June 9, 2023 for failing to maintain $1.00 minimum bid price over 30 consecutive business days.
- Has 180 calendar days, until December 6, 2023, to regain compliance by closing at or above $1.00 for 10 consecutive business days.
- If not cured, may seek a second 180-day period if it meets other listing standards and notifies intent to cure.
- Failure to regain compliance could lead to delisting; company may appeal to Nasdaq hearings panel.
- Company states there is no assurance it will regain compliance or secure an extension.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1859007/000149315223020803/0001493152-23-020803-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1859007/000149315223020803/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-020803

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer